FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Docetaxel Injection Recall

Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Mar 20, 2019
Recall ID
D-1001-2019
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Docetaxel Injection starting Mar 6, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1001-2019 on Mar 20, 2019. Reason: Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance. Status: Terminated.

Why it was recalled

Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.

Product description

Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.

Lot numbers, UPCs & expiration codes

Lot#: H7081, Exp 07/2019

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1001-2019
Classification
Class II
Status
Terminated
Recall initiated
Mar 6, 2019
FDA report date
Mar 20, 2019
Quantity
5,755 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1001-2019, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
82323
Address
107 College Rd E
Code information
Lot#: H7081, Exp 07/2019
Postal code
08540-6623
Report date
Mar 20, 2019
Product type
Drugs
Recall number
D-1001-2019
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
5,755 vials
Termination date
May 16, 2022
Reason for recall
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 6, 2019
Initial firm notification
Letter
Center classification date
Mar 12, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1001-2019, published Mar 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls